Antithrombin Dublin (-3 Val----Glu): an N-terminal variant which has an aberrant signal peptidase cleavage site.

Article Details

Citation

Daly M, Bruce D, Perry DJ, Price J, Harper PL, O'Meara A, Carrell RW

Antithrombin Dublin (-3 Val----Glu): an N-terminal variant which has an aberrant signal peptidase cleavage site.

FEBS Lett. 1990 Oct 29;273(1-2):87-90.

PubMed ID
1977621 [ View in PubMed
]
Abstract

Antithrombin Dublin is an electrophoretically fast variant of antithrombin which has normal heparin affinity. Direct sequencing of amplified exon 2 revealed a Val----Glu substitution at position -3. N-terminal sequencing of antithrombin from two individuals, heterozygous for the Dublin mutation, showed the presence of a truncated antithrombin in which the N-terminal dipeptide is absent. We propose that the prepeptide mutation redirects signal peptidase cleavage to a site two amino acids downstream into the mature protein.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Antithrombin-IIIP01008Details